These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 28342763)

  • 1. Serotonin and neuroplasticity - Links between molecular, functional and structural pathophysiology in depression.
    Kraus C; Castrén E; Kasper S; Lanzenberger R
    Neurosci Biobehav Rev; 2017 Jun; 77():317-326. PubMed ID: 28342763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic SSRI Treatment, but Not Norepinephrine Reuptake Inhibitor Treatment, Increases Neurogenesis in Juvenile Rats.
    Hovorka M; Ewing D; Middlemas DS
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study the effects of neuroplasticity on major depression disorder in rTMS combined with antidepressant treatments].
    Zheng B; Zheng Z; Zou K; Yan TT; Mo LL; Chen ZS; Sun XL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Jul; 44(4):596-601. PubMed ID: 24059116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of cognitive dysfunction in major depressive disorder--a review of the preclinical evidence for efficacy of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors and the multimodal-acting antidepressant vortioxetine.
    Pehrson AL; Leiser SC; Gulinello M; Dale E; Li Y; Waller JA; Sanchez C
    Eur J Pharmacol; 2015 Apr; 753():19-31. PubMed ID: 25107284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Depression and neuroplasticity: implication of serotoninergic systems].
    Daszuta A; Ban M; Soumier A; Hery M; Mocaer E
    Therapie; 2005; 60(5):461-8. PubMed ID: 16433011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular imaging of the serotonin transporter availability and occupancy by antidepressant treatment in late-life depression.
    Smith GS; Kuwabara H; Gould NF; Nassery N; Savonenko A; Joo JH; Bigos KL; Kraut M; Brasic J; Holt DP; Hall AW; Mathews WB; Dannals RF; Nandi A; Workman CI
    Neuropharmacology; 2021 Aug; 194():108447. PubMed ID: 33450276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escitalopram modulates learning content-specific neuroplasticity of functional brain networks.
    Klöbl M; Seiger R; Vanicek T; Handschuh P; Reed MB; Spurny-Dworak B; Ritter V; Godbersen GM; Gryglewski G; Kraus C; Hahn A; Lanzenberger R
    Neuroimage; 2022 Feb; 247():118829. PubMed ID: 34923134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serotonin and antidepressant treatments: new issues about the therapeutic mechanism of action].
    Lista Varela A
    Vertex; 2003; 14(51):25-9. PubMed ID: 12690406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Cerebral Small Vessel Disease With Antidepressant Use and Depression: 3C Dijon Magnetic Resonance Imaging Study.
    Tully PJ; Alpérovitch A; Soumaré A; Mazoyer B; Debette S; Tzourio C
    Stroke; 2020 Feb; 51(2):402-408. PubMed ID: 31826735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating the monoamine, neurotrophin and cytokine hypotheses of depression--a central role for the serotonin transporter?
    Haase J; Brown E
    Pharmacol Ther; 2015 Mar; 147():1-11. PubMed ID: 25444754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gestational stress and fluoxetine treatment differentially affect plasticity, methylation and serotonin levels in the PFC and hippocampus of rat dams.
    Gemmel M; Rayen I; van Donkelaar E; Loftus T; Steinbusch HW; Kokras N; Dalla C; Pawluski JL
    Neuroscience; 2016 Jul; 327():32-43. PubMed ID: 27060483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VORTIOXETINE - THE NEW ANTIDEPRESSANT AGENT WITH PROCOGNITIVE PROPERTIES.
    Dziwota E; Olajossy M
    Acta Pol Pharm; 2016 Nov; 73(6):1433-1437. PubMed ID: 29634095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gray matter and intrinsic network changes in the posterior cingulate cortex after selective serotonin reuptake inhibitor intake.
    Kraus C; Ganger S; Losak J; Hahn A; Savli M; Kranz GS; Baldinger P; Windischberger C; Kasper S; Lanzenberger R
    Neuroimage; 2014 Jan; 84():236-44. PubMed ID: 23988273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroplasticity and memory formation in major depressive disorder: an imaging genetics perspective on serotonin and BDNF.
    Kuhn M; Popovic A; Pezawas L
    Restor Neurol Neurosci; 2014; 32(1):25-49. PubMed ID: 23603442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single dose of vortioxetine, but not ketamine or fluoxetine, increases plasticity-related gene expression in the rat frontal cortex.
    du Jardin KG; Müller HK; Sanchez C; Wegener G; Elfving B
    Eur J Pharmacol; 2016 Sep; 786():29-35. PubMed ID: 27235984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT3) levels in post-mortem brain tissue from patients with depression compared to healthy individuals - a proof of concept study.
    Sheldrick A; Camara S; Ilieva M; Riederer P; Michel TM
    Eur Psychiatry; 2017 Oct; 46():65-71. PubMed ID: 29102768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal Subfields in Acute and Remitted Depression-an Ultra-High Field Magnetic Resonance Imaging Study.
    Kraus C; Seiger R; Pfabigan DM; Sladky R; Tik M; Paul K; Woletz M; Gryglewski G; Vanicek T; Komorowski A; Kasper S; Lamm C; Windischberger C; Lanzenberger R
    Int J Neuropsychopharmacol; 2019 Aug; 22(8):513-522. PubMed ID: 31175352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine neurocircuitry in depression and strategies for new treatments.
    Hamon M; Blier P
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of adult hippocampal neuroplasticity in major depression: pathogenesis and therapeutic implications.
    Tartt AN; Mariani MB; Hen R; Mann JJ; Boldrini M
    Mol Psychiatry; 2022 Jun; 27(6):2689-2699. PubMed ID: 35354926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.